The therapeutic development of Scleroderma is burgeoning with immense business potential

Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 Category: Healthcare

Insert Image Height - 3.60 Width – 4.98

www.researchonglobalmarkets.com

Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 Report Coverage

• A snapshot of the global therapeutic scenario for Systemic Sclerosis (Scleroderma) • A review of the Scleroderma products under development by companies and universities or research institutes based on information derived from company and industry-specific sources • Coverage of products based on various stages of development ranging from discovery till registration stages • A feature on pipeline projects on the basis of monotherapy and combined therapeutics • Coverage of the Scleroderma pipeline on the basis of route of administration and molecule type www.researchonglobalmarkets.com

Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 Report Coverage (Continued)

• All discontinued pipeline projects • Latest news and deals related to the products

www.researchonglobalmarkets.com

Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 Report Benefits

• Identify and understand diverse types of therapeutics under development for Scleroderma • Identify emerging players with potentially strong product portfolio • Design effective counter-strategies to gain competitive advantage • Plan mergers and acquisitions effectively by identifying players of the most promising pipeline • Devise corrective measures for pipeline projects by understanding Scleroderma pipeline depth and focus of indication therapeutics • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope www.researchonglobalmarkets.com

Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 Report Benefits (Continued)

• Modify your therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

www.researchonglobalmarkets.com

Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 Table of Contents

• Introduction • Overview • Comparative Analysis • R&D Progress • Appendix • Methodology

www.researchonglobalmarkets.com

Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 Report Details

• • • • • • • • •

Publish date: 29th Oct, 2013 Number of slides: 87 Geographic coverage: Global Available format: PDF, CD, Hardcopy Price for Single User License: USD 2,000 Price for Site License: USD 4,000 Price for Global User License: USD 6,000 Delivery Time: Within 1 business day Payment Modes: Credit/Debit Card, RTGS/Wire Transfer, Google Wallet, PayPal www.researchonglobalmarkets.com

Interested in this report?

To view more details regarding this premium market research report, Please click here

For further information, get in touch with us: E-mail: support@researchonglobalmarkets.com Call: US: +1 866 325 7446 UK: +44 203 514 2363 Others: +91 22 4098 7600 About Us Research on Global Markets is a leading source for market research on various sectors globally offering premium research content from worldwide publishers of market research reports Industry Segments Automotive & Transport

Consumer goods

Agriculture

Food and Beverage

Energy and Utilities

Public Sector

Manufacturing & Construction

Healthcare

Media & Entertainment

IT, Telecom & Electronics

Services

Others

www.researchonglobalmarkets.com